Department of Chemistry and Biology, Ryerson University, Toronto, ON, Canada.
Department of Pathology and Molecular Medicine, McNaster University, Hamilton, ON, Canada; Shift Health, Toronto, ON, Canada.
Lancet. 2019 Feb 9;393(10171):587-593. doi: 10.1016/S0140-6736(18)33188-X.
In August 2018, the president of the World Bank noted that "'Human capital'-the potential of individuals-is going to be the most important long-term investment any country can make for its people's future prosperity and quality of life". Nevertheless, leaders and practitioners in academic science and medicine continue to be unaware of and poorly educated about the nature, extent, and impact of barriers to full participation of women and minorities in science and medicine around the world. This lack of awareness and education results in failures to fully mobilise the human capital of half the population and limits global technological and medical advancements. The chronic lack of recruitment, promotion, and retention of women in science and medicine is due to systemic, structural, organisational, institutional, cultural, and societal barriers to equity and inclusion. These barriers must be identified and removed through increased awareness of the challenges combined with evidence-based, data-driven approaches leading to measurable targets and outcomes. In this Review, we discuss these issues and highlight actions that could achieve gender equality in science and medicine. We survey approaches and insights that have helped to identify and remove systemic bias and barriers in science and medicine, and propose tools that will help organisational change toward gender equality. We describe tools that include formal legislation and mandated quotas at national or large-scale levels (eg, gender parity), techniques that increase fairness (eg, gender equity) through facilitated organisational cultural change at institutional levels, and professional development of core competencies at individual levels. This Review is not intended to be an extensive analysis of all the literature currently available on achieving gender equality in academic medicine and science, but rather, a reflection on finding multifactorial solutions.
2018 年 8 月,世界银行行长指出,“‘人力资本’——个人的潜力——将成为任何国家为人民未来的繁荣和生活质量做出的最重要的长期投资”。然而,学术科学和医学领域的领导者和从业者仍然没有意识到,也没有接受过关于世界各地女性和少数族裔全面参与科学和医学所面临的障碍的性质、程度和影响的教育。这种缺乏意识和教育导致未能充分调动一半人口的人力资本,并限制了全球技术和医疗的进步。在科学和医学领域,女性长期以来在招聘、晋升和留用方面的不足,是由于在公平和包容方面存在系统性、结构性、组织性、制度性、文化性和社会性障碍。必须通过提高对这些挑战的认识,并采取基于证据、数据驱动的方法来实现可衡量的目标和结果,从而消除这些障碍。在这篇综述中,我们讨论了这些问题,并强调了可以实现科学和医学领域性别平等的行动。我们调查了有助于识别和消除科学和医学中系统偏见和障碍的方法和见解,并提出了有助于组织向性别平等转变的工具。我们描述了一些工具,包括国家或大规模层面的正式立法和强制性配额(如性别均等),以及在机构层面通过促进组织文化变革来增加公平性的技术(如性别公平),以及在个人层面发展核心能力的专业发展。这篇综述并不是对目前关于在学术医学和科学中实现性别平等的所有文献的广泛分析,而是对寻找多因素解决方案的反思。